OncoSil Medical Brand Refresh
Designhouse has completed a full brand refresh for OncoSil, a global medical device company at the forefront of pancreatic cancer treatment. Founded in 2004 and headquartered in Sydney, Australia, OncoSil has recently received regulatory approval in both Switzerland and Malaysia.
This marks a significant step in its international expansion. To reflect this growing global presence and cement its authority in oncology, a refreshed brand was required.
The brief called for a more dynamic identity that balanced scientific rigour with human warmth. Designhouse evolved the existing brand assets, introduced a refined colour palette of dark navy and electric blue to convey trust and transformation, and adopted the semi-condensed typeface FS Industrie for its clean, technical quality. A new strapline, “Targeted Approach, Positive Impact,” was developed to anchor the brand’s refreshed direction.
The work extended well beyond visual identity. We produced a new
- website
- social media assets,
- exhibition graphics
- corporate literature
- a suite of video content, including mode of action and dose preparation films tailored for healthcare professionals.
- annual report
- radiation safety guidelines
- corporate brand film to introduce the new identity to employees and external stakeholders
OncoSil’s Marketing Director, Cynthia Azucena, noted that Designhouse delivered creative work and well-considered strategic input, with the new identity effectively capturing the company’s human-centric approach to pioneering science.
Read the full case study here
Designhouse has partnered with FTSE 250 companies and global enterprises for over 50 years, delivering strategic brand consultancy that creates measurable competitive advantage. If you’d like to discuss your brand challenges, we’d be glad to talk.
